Denys Bezman, | |
9801 Frontier Ave Se, Snoqualmie, WA 98065-5200 | |
(425) 831-3561 | |
Not Available |
Full Name | Denys Bezman |
---|---|
Gender | Male |
Speciality | Licensed Vocational Nurse |
Location | 9801 Frontier Ave Se, Snoqualmie, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396462560 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164X00000X | Licensed Vocational Nurse | LP60793211 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Denys Bezman, 9801 Frontier Ave Se, Snoqualmie, WA 98065-5200 Ph: (425) 831-3561 | Denys Bezman, 9801 Frontier Ave Se, Snoqualmie, WA 98065-5200 Ph: (425) 831-3561 |
News Archive
Community Health Solutions of America, LLC of St. Petersburg, FL, will help its healthcare clients better manage their patient populations and track their clinical and financial objectives with quality-focused tools from MEDai, an Elsevier company and a leading provider of predictive analytic solutions.
Government actuaries expect that U.S. health spending will increase over the next decade as a result of an aging population, a rebounding economy and the health law's expanded insurance coverage, but the growth rates will be lower than those seen for most of the last two decades.
A machine learning method analyzing large amounts of health information has potential in assessing the risk of cognitively healthy older people for later dementia, according to research published in the Journal of Alzheimer's Disease. The new risk assessment tool also presents the individual risk profile in a quickly interpretable visual form.
A recent study showed that medical provider training, new clinic policies and efforts to "taper" opioid use for pain treatment could significantly reduce the level of opioid medication that patients used - a limited but positive step for a nation enmeshed in opioid use, abuse and overdose deaths.
Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, and Synerx Pharma, LLC, announced today the launch of Fomepizole Injection, the generic equivalent of Antizol(R) from Paladin Labs, Inc.
› Verified 5 days ago